<html><body><h2>Case: 1305833210743</h2>
<patient name=1111706>
59.0 year old Asian_or_Pacific-Islander_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">59</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">8</td><td width="200">1956-10-10</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">71</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">3</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">124</td><td width="200">1956-9-26</td></tr>
<tr><td width="200">Chloride</td><td width="200">105.0</td><td width="200">1956-10-10</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">46</td><td width="200">1956-9-26</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">69</td><td width="200">1959-8-20</td></tr>
<tr><td width="200">BNP</td><td width="200">447</td><td width="200">1956-9-25</td></tr>
<tr><td width="200">Weight</td><td width="200">183</td><td width="200">1959-8-20</td></tr>
<tr><td width="200">HbA1C</td><td width="200">7</td><td width="200">1956-9-25</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">66</td><td width="200">1956-9-26</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">190</td><td width="200">1956-9-26</td></tr>
<tr><td width="200">SGOT</td><td width="200">84</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">114</td><td width="200">1959-8-20</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">1</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">Height</td><td width="200">67</td><td width="200">1959-8-19</td></tr>
<tr><td width="200">Potassium</td><td width="200">3</td><td width="200">1956-10-10</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">190</td><td width="200">1956-9-26</td></tr>
<tr><td width="200">BUN</td><td width="200">18</td><td width="200">1956-10-10</td></tr>
<tr><td width="200">HCT</td><td width="200">44</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">HGB</td><td width="200">14</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">Sodium</td><td width="200">143</td><td width="200">1956-10-10</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">Creatinine</td><td width="200">0.9</td><td width="200">1956-10-10</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">7</td><td width="200">1956-9-25</td></tr>
<tr><td width="200">Pulse</td><td width="200">66</td><td width="200">1959-8-20</td></tr>
<tr><td width="200">PLT</td><td width="200">177</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">WBC</td><td width="200">8</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1958-7-18</td></tr>
<tr><td width="200">SGPT</td><td width="200">64</td><td width="200">1956-9-29</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1958-7-18</td></tr>
<tr><td width="200">Coronary_Artery_Disease</td><td width="200"></td><td width="200">1959-8-19</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1959-8-20</td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">Asian_or_Pacific-Islander_Non-Hispanic</td><td width="200"></td></tr>
</table>
<p><b>Medications:</b> aspirin(0.0) metformin(2000.0) digoxin(0.25) carvedilol(25.0) glipizide(2.5) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hypokalemia in the past[Potassium(3.2/1956-10-10)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of cononary artery disease]()</td></tr>
<tr><td width="200">Diabetes WITHOUT proteinuria/renal manifestations</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of diabetes mellitus && Absence of diabetic with renal manifestations && Absence of diabetic nephropathy && Absence of diabetic nephrosis && Proteinuria equals trace or above && Absence of ARB]()</td></tr>
<tr><td width="200">K<3.5 (most recent) NOT ON HCTZ</td>
<td width="200"></td>
<td width="200"> Recent Hypokalemia[Potassium(3.2/1956-10-10) && thiazide diuretics not being used]()</td></tr>
<tr><td width="200">DM (2ary prev)  BP controlled</td>
<td width="200"></td>
<td width="200"> Diabetes (Secondary Prevention)[Treatment_Diastolic_BP(69/null) && Treatment_Systolic_BP(114/null) && presence of diabetes mellitus]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(69/null) && Treatment_Systolic_BP(114/null) && presence of heart failure]()</td></tr>
<tr><td width="200">Hypokalemia</td>
<td width="200"></td>
<td width="200"> Hypokalemia(<3.5mg/dl)[Potassium(3.2/1956-10-10)]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(69/null) && Treatment_Systolic_BP(114/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[presence of diabetes mellitus]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[Potassium(3.2/1956-10-10) && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200"></td>
<td width="200"> Active Liver Disease[SGOT(84.0/1956-9-29)]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1959-08-20</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1959-08-19</td>
<td width="200"> Coronary_Artery_Disease()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1958-07-18</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 100 mg/dL(CHD Risk Equivalent)
<p><b>Reached goal?</b> failed(LDL_Cholesterol(124.0/1956-9-26))
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(69/null) && Treatment_Systolic_BP(114/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
<li>Diuretics and salt restriction are indicated if there is evidence of fluid retention. (Level of Evidence: C)
<li>Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

Diuretics and salt restriction are indicated if there is evidence of fluid retention. (Level of Evidence: C)
<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>No comment
</ul>
<li>No comment
</ul>
</ul>
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>No comment
</ul>
<li>No comment
</ul>
<li>No comment
</ul>
</ul>
</ul>
</ul>
</ul>
</body></html>